GLYCOMIMETICS
GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.
GLYCOMIMETICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2003-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.glycomimetics.com
Total Employee:
51+
Status:
Active
Contact:
2402431207
Email Addresses:
[email protected]
Total Funding:
194.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Ampio Pharmaceuticals
Ampio Pharmaceuticals is a biopharmaceutical firm that discovers and develops novel therapies for treating inflammatory conditions.
Calithera Biosciences
Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Epirium Bio
Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.
Cascadian Therapeutics
Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.
CTI BioPharma
CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.
Innovation Pharmaceuticals
Innovation Pharmaceuticals is a biopharmaceutical company developing small molecule therapies in areas of unmet medical needs.
Celsion
Celsion is a biopharmaceutical company which develops innovative, targeted therapies that address unmet medical needs in oncology.
Celtaxsys
Celtaxsys is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer.
Cequent Pharmaceuticals
Cequent is a biopharmaceutical company pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases.
Conatus Pharmaceuticals
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals develops small molecule therapeutics for treating life-threatening medical conditions.
Immunomedics
Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Molecular Templates
Molecular Templates develops novel therapeutic compounds for cancer.
Palatin Technologies
Palatin Technologies, a biopharmaceutical company, develops targeted receptor specific peptide therapeutics for the treatment of diseases.
Phoenix Molecular Designs
Phoenix Molecular Designs is a biopharmaceutical company designing precise cancer therapeutics by targeting kinases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Sequoia Sciences
Sequoia Sciences is a pharmaceutical company discovering and developing new medicines for the treatment of bacterial infections and cancers.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
TesoRx Pharma
TesoRx is a virtual pharmaceutical company developing and commercializing pharmaceutical products.
Prescient Therapeutics
Prescient Therapeutics is a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Novartis Venture Fund
Novartis Venture Fund investment in Series C - GlycoMimetics
Sanofi Ventures
Sanofi Ventures investment in Series C - GlycoMimetics
New Enterprise Associates
New Enterprise Associates investment in Series C - GlycoMimetics
Alliance Technology Ventures
Alliance Technology Ventures investment in Series C - GlycoMimetics
Anthem Capital Management
Anthem Capital Management investment in Series C - GlycoMimetics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - GlycoMimetics
Anthem Capital Management
Anthem Capital Management investment in Series B - GlycoMimetics
PTV Healthcare Capital
PTV Healthcare Capital investment in Series B - GlycoMimetics
Alliance Technology Ventures
Alliance Technology Ventures investment in Series B - GlycoMimetics
New Enterprise Associates
New Enterprise Associates investment in Series B - GlycoMimetics
Key Employee Changes
Official Site Inspections
http://www.glycomimetics.com Semrush global rank: 9.87 M Semrush visits lastest month: 93
- Host name: mi3-ts2.a2hosting.com
- IP address: 70.32.23.55
- Location: Ann Arbor United States
- Latitude: 42.2503
- Longitude: -83.8393
- Metro Code: 505
- Timezone: America/Detroit
- Postal: 48106
